Structure Therapeutics (GPCR) Other Working Capital Changes (2022 - 2026)

Structure Therapeutics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at $206000.0 for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 144.88% year-over-year to $206000.0; the TTM figure through Mar 2026 stood at -$1.6 million (up 5.28% YoY), while the FY2025 annual figure was -$2.3 million, down 44.31% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at $206000.0, up from -$603000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $9.1 million in Q4 2025, with the low at -$2.4 million in Q2 2024.
• The 5-year median for Other Working Capital Changes is $893000.0 (2022), against an average of $1.8 million.
• The sharpest annual moves came in 2024 and 2026: Other Working Capital Changes tumbled 636.62% in 2024, then jumped 144.88% in 2026.
• Structure Therapeutics' Other Working Capital Changes stood at -$84000.0 in 2022, then rose by 15.48% to -$71000.0 in 2023, then sank by 636.62% to -$523000.0 in 2024, then decreased by 15.3% to -$603000.0 in 2025, then soared by 134.16% to $206000.0 in 2026.
• Business Quant data shows GPCR's Other Working Capital Changes at $206000.0 in Q1 2026, -$603000.0 in Q4 2025, and -$601000.0 in Q3 2025.